St. Jude Medical (STJ) Announces FDA Approval, U.S. Launch of Medical Device to Reduce Risk of Recurrent Ischemic Stroke in Patients with PFO

St. Jude Medical Announces FDA Approval and U.S. Launch of the First and Only Medical Device Indicated to Reduce the Risk of Recurrent Ischemic Stroke in Patients with a PFO

The AMPLATZER PFO Occluder has been shown to provide a clinically meaningful reduction in the risk of recurrent stroke among patients with a PFO compared to medical management alone

ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced the U.S. Food and Drug Administration (FDA) approval and launch of the AMPLATZER PFO Occluder to help reduce the risk of recurrent ischemic strokes in patients diagnosed with a patent foramen ovale (PFO) a small opening between the upper chambers of the... More